I am/have/had
I am looking for
Advanced Filters
Found 3 clinical trials
Capivasertib+Abiraterone as Treatment for Patients With Metastatic Hormone-sensitive Prostate Cancer and PTEN Deficiency
This study will assess the efficacy and safety of capivasertib plus abiraterone (+prednisone/prednisolone) plus androgen deprivation therapy (ADT) versus placebo plus abiraterone (+prednisone/prednisolone) plus ADT in participants with mHSPC whose tumours are characterised by PTEN deficiency.
soft tissue lesion
androgen suppression
steroid therapy
gonadotropin releasing hormone
antiandrogen therapy
- 0 views
- 16 Feb, 2024
- 107 locations
Study to Evaluate the Safety Tolerability Pharmacokinetics and Pharmacodynamics of CC-94676 in Subjects With Metastatic Castration-Resistant Prostate Cancer
This is a first in human study to assess the safety, tolerability, PK, PD and preliminary efficacy of CC-94676 in men with progressive metastatic castration-resistant prostate cancer.
androgen suppression
metastatic castration-resistant prostate cancer
gonadotropin releasing hormone
antiandrogen therapy
adenocarcinoma
- 0 views
- 05 Aug, 2020